Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Darren Sissons
Straumann Holding AGSTMN-SWXTOP PICKDec 08, 2025
Darren SissonsOwned
N/A
Stock price when the opinion was issued
medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick Mar 25/19, Up 20%) They're the world's biggest producer of dental implants. It's a cyclical business, but more people are buying implants instead of dentures, so there's long-term potential growth. Their plants are in Thailand and the Phillippines compared to their competition in pricier North America.
medical services
PAST TOP PICK
(A Top Pick Aug 20/18, Up 4%) They're the leader in dental implants and gaining ground in aligners. The risk is that dental implants are highly discretionary. So, if the economy weakens, this business is in trouble. He expects the economy to grow.
David FingoldOwned
medical services
TOP PICK
Dental implants. They had to change out management. They moved to more modern dental implants. They bought Clear Correct a while ago for cosmetic dentistry. (Analysts’ price target is $806.44)
David FingoldOwned
medical services
TOP PICK
They're the world leader in dental implants. They're rapidly taking market share in the partially and fully tapared implant launches happening in the fall. They can grow revenues significantly and market expansion. Growth in the last quarter was 20%. (0.6% dividend, Analysts' price target: CHF 793.07)
David FingoldOwned
medical services
They make dentistry equipment: crowns, restorative items, etc. They have a premium brand as well as other brands. The market in Canada grows at 9.5% organically. They have a very good balance sheet and can do tuck-in acquisitions. The stock sold off on the concern over tariffs but tariffs are largely irrelevant. It can supply the US and Canadian markets and international markets which are growing, including China, Japan, Korea etc., with production facilities in these countries. It may do some re-structuring and should continue to move forward, Buy 13 Hold 7 Sell 3
(Analysts’ price target is $111.13)